Propofol is an intravenous anesthetic agent used for the induction and maintenance of anesthesia, as well as for sedation during mechanical ventilation in intensive care units [1]. It is also employed for procedural sedation [2].
How does propofol work?
Propofol's mechanism of action involves enhancing the activity of gamma-aminobutyric acid (GABA) at the GABAA receptor, which is a ligand-gated ion channel [3]. This enhancement leads to an increased inhibitory neurotransmission in the brain, resulting in its sedative and anesthetic effects [3].
What are the side effects of propofol?
Common side effects of propofol include pain or stinging at the injection site, transient respiratory depression, and hypotension [4]. Less common but serious side effects can include propofol infusion syndrome, which is a rare but potentially fatal condition characterized by metabolic acidosis, rhabdomyolysis, cardiac failure, and hyperkalemia, particularly with prolonged high-dose infusions [5]. Allergic reactions are also possible [4].
How is propofol administered?
Propofol is administered intravenously, either as a bolus injection for induction of anesthesia or as a continuous infusion for maintenance of anesthesia or sedation [1]. Dosing is carefully titrated based on the patient's response and clinical situation [2].
What are the different formulations of propofol?
Propofol is available as an emulsion for injection. It is important to note that propofol emulsions are a lipid-based system, and their formulation can be a target for microbial contamination if aseptic techniques are not strictly maintained during administration [6].
When does propofol patent exclusivity expire?
Information regarding specific patent exclusivity for propofol is not readily available in the provided context. Patent information for pharmaceuticals can be complex and subject to various extensions and challenges. Resources like DrugPatentWatch.com can provide detailed insights into patent expiry dates and related intellectual property [7].